Cargando…
A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors
BACKGROUND: Less than half of unselected metastatic cancer patients benefit from the immune checkpoint inhibitor (ICI) therapy. Systemic cancer-related inflammation may influence the efficacy of ICIs and thus, systemic inflammatory markers could have prognostic and/or predictive potential in ICI the...
Autores principales: | Tiainen, Satu, Nurmela, Veera, Selander, Tuomas, Turunen, Patrik, Pasonen-Seppänen, Sanna, Kettunen, Tiia, Kuittinen, Outi, Auvinen, Päivi, Rönkä, Aino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694914/ http://dx.doi.org/10.1186/s12885-023-11699-0 |
Ejemplares similares
-
Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events
por: Jokimäki, Anna, et al.
Publicado: (2023) -
The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer
por: Jääskeläinen, Minna M., et al.
Publicado: (2023) -
The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma
por: Takabe, Piia, et al.
Publicado: (2022) -
Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
por: Puhakka, Inka, et al.
Publicado: (2022) -
Peritumoral ADC values in breast cancer: region of interest selection, associations with hyaluronan intensity, and prognostic significance
por: Kettunen, Tiia, et al.
Publicado: (2019)